OIL TYPE COMPARISON
Agarwood (Oud) Attar
Every collected brand, with the source details and chemical context laid out together.
1 products have linked report evidence
Read the reported chemistry below. A report can be linked to a product or associated by supplier and oil identity; the distinction stays visible.
1 products have source findings
Open the product evidence to see the named observation, its source, and any matched historical range.
1 products have missing evidence
Missing batch links, identity details, or comparable history limit what can be concluded. Gray means unknown, never a failed oil.
Compare reported chemistry
Choose up to three products and the exact reports to compare. Each column keeps its batch and source context visible.
Lotus Garden Botanicals
Agarwood (Oud) Attar
- Batch
- AGWA922EO1215
- Botanical species
- Aquilaria crassna+Santalum
- Origin / plant part
- Cambodia · Unknown part
- Extraction / basis
- Steam Distillation [Distilled · area percent
AUTOMATIC OIL REVIEW
More evidence needed for this report
| Chemical constituent | Lotus Garden BotanicalsAGWA922EO1215 |
|---|---|
| 1 Santene 9.765 | 0.02%Context not comparable0 comparable historical reports |
| 10 trans-alpha-Bergamotene 44.773 | 0.19%Context not comparable0 comparable historical reports |
| 100 Unidentified 65.723 | 0.04%Context not comparable0 comparable historical reports |
| 101 Unidentified 65.944 | 0.33%Context not comparable0 comparable historical reports |
| 102 Unidentified 66.150 | 0.04%Context not comparable0 comparable historical reports |
| 103 Unidentified 66.538 | 0.02%Context not comparable0 comparable historical reports |
| 104 Unidentified 66.934 | 0.10%Context not comparable0 comparable historical reports |
| 105 Unidentified 67.204 | 0.05%Context not comparable0 comparable historical reports |
| 106 Santalol analogue 67.350 | 0.02%Context not comparable0 comparable historical reports |
| 107 Unidentified 68.016 | 0.05%Context not comparable0 comparable historical reports |
| 108 Unidentified 68.841 | 0.02%Context not comparable0 comparable historical reports |
| 109 Unidentified 68.986 | 0.02%Context not comparable0 comparable historical reports |
| 11 epi-beta-Santalene 45.649 | 0.81%Context not comparable0 comparable historical reports |
| 110 Unidentified 69.478 | 0.02%Context not comparable0 comparable historical reports |
| 111 Unidentified 73.081 | 0.02%Context not comparable0 comparable historical reports |
| 112 Unidentified 73.344 | 0.07%Context not comparable0 comparable historical reports |
| 113 1,5-Diphenyl-3-pentanone 76.746 | 0.01%Context not comparable0 comparable historical reports |
| 12 Sesquisabinene 46.049 | 0.02%Context not comparable0 comparable historical reports |
| 13 beta-Santalene 46.408 | 1.24%Context not comparable0 comparable historical reports |
| 14 alpha-Acoradiene 46.686 | 0.02%Context not comparable0 comparable historical reports |
| 15 beta-Acoradiene 46.835 | 0.01%Context not comparable0 comparable historical reports |
| 16 4,5-di-epi-aristolochene 47.064 | 0.01%Context not comparable0 comparable historical reports |
| 17 Unidentified 47.429 | 0.76%Context not comparable0 comparable historical reports |
| 18 gamma-Curcumene 47.556 | 0.11%Context not comparable0 comparable historical reports |
| 19 Ar-Curcumene 47.754 | 0.15%Context not comparable0 comparable historical reports |
| 2 Linalool 22.458 | 0.02%Context not comparable0 comparable historical reports |
| 20 trans-beta-Bergamotene 47.935 | 0.11%Context not comparable0 comparable historical reports |
| 21 beta-Vetispirene 48.232 | 0.02%Context not comparable0 comparable historical reports |
| 22 Helifolen-12-al analogue 48.438 | 0.03%Context not comparable0 comparable historical reports |
| 23 Unidentified 48.585 | 0.03%Context not comparable0 comparable historical reports |
| 24 Unidentified 48.675 | 0.01%Context not comparable0 comparable historical reports |
| 25 alpha-Bulnesene 49.013 | 0.02%Context not comparable0 comparable historical reports |
| 26 beta-Dihydroagarofuran 49.224 | 0.03%Context not comparable0 comparable historical reports |
| 27 beta-Bisabolene 49.409 | 0.16%Context not comparable0 comparable historical reports |
| 28 beta-Curcumene 49.510 | 0.26%Context not comparable0 comparable historical reports |
| 29 Unidentified 49.580 | 0.03%Context not comparable0 comparable historical reports |
| 3 Methyl phenethyl ketone 32.170 | 0.10%Context not comparable0 comparable historical reports |
| 30 Sesquicineole 49.732 | 0.02%Context not comparable0 comparable historical reports |
| 31 Unidentified 50.000 | 0.18%Context not comparable0 comparable historical reports |
| 32 beta-Sesquiphellandrene 50.360 | 0.02%Context not comparable0 comparable historical reports |
| 33 trans-gamma-Bisabolene 50.530 | 0.01%Context not comparable0 comparable historical reports |
| 34 Kessane 50.651 | 0.01%Context not comparable0 comparable historical reports |
| 35 trans-alpha-Bisabolene 51.370 | 0.02%Context not comparable0 comparable historical reports |
| 36 Unidentified 51.442 | 0.21%Context not comparable0 comparable historical reports |
| 37 Unidentified 51.530 | 0.07%Context not comparable0 comparable historical reports |
| 38 Unidentified 51.765 | 0.07%Context not comparable0 comparable historical reports |
| 39 Unidentified 52.117 | 0.11%Context not comparable0 comparable historical reports |
| 4 Santalal analogue 38.603 | 0.07%Context not comparable0 comparable historical reports |
| 40 trans-Nerolidol 52.556 | 0.36%Context not comparable0 comparable historical reports |
| 41 Unidentified 52.668 | 0.49%Context not comparable0 comparable historical reports |
| 42 Dendrolasin 53.033 | 0.26%Context not comparable0 comparable historical reports |
| 43 Unidentified 53.150 | 0.03%Context not comparable0 comparable historical reports |
| 44 Unidentified 53.301 | 0.05%Context not comparable0 comparable historical reports |
| 45 Unidentified 53.520 | 0.03%Context not comparable0 comparable historical reports |
| 46 Unidentified 53.642 | 0.04%Context not comparable0 comparable historical reports |
| 47 Unidentified 54.288 | 0.04%Context not comparable0 comparable historical reports |
| 48 Guaiol 54.640 | 0.05%Context not comparable0 comparable historical reports |
| 49 Unidentified 54.818 | 0.14%Context not comparable0 comparable historical reports |
| 5 trans-alpha-Santalal 39.539 | 0.01%Context not comparable0 comparable historical reports |
| 50 Unidentified 55.067 | 0.04%Context not comparable0 comparable historical reports |
| 51 Unidentified 55.563 | 0.01%Context not comparable0 comparable historical reports |
| 52 Unidentified 55.685 | 0.05%Context not comparable0 comparable historical reports |
| 53 epi-gamma-Eudesmol 56.111 | 0.29%Context not comparable0 comparable historical reports |
| 54 Unidentified 56.319 | 0.01%Context not comparable0 comparable historical reports |
| 55 gamma-Eudesmol 56.659 | 0.16%Context not comparable0 comparable historical reports |
| 56 Hinesol 56.895 | 0.31%Context not comparable0 comparable historical reports |
| 57 Unidentified 57.206 | 0.01%Context not comparable0 comparable historical reports |
| 58 Unidentified 57.370 | 0.01%Context not comparable0 comparable historical reports |
| 59 Unidentified 57.473 | 0.25%Context not comparable0 comparable historical reports |
| 6 Unidentified 41.271 | 0.02%Context not comparable0 comparable historical reports |
| 60 Agarospirol analogue 57.620 | 0.03%Context not comparable0 comparable historical reports |
| 61 Valerianol 57.870 | 0.19%Context not comparable0 comparable historical reports |
| 62 Khusilal 57.921 | 0.83%Context not comparable0 comparable historical reports |
| 63 Unidentified 58.157 | 0.14%Context not comparable0 comparable historical reports |
| 64 trans-alpha-Santalal 58.247 | 0.30%Context not comparable0 comparable historical reports |
| 66 Unidentified 58.712 | 0.74%Context not comparable0 comparable historical reports |
| 67 epi-beta-Bisabolol 58.848 | 0.28%Context not comparable0 comparable historical reports |
| 68 cis-alpha-Santalol 59.192 | 36.99%Context not comparable0 comparable historical reports |
| 69 cis-alpha-Santalal 59.245 | 1.00%Context not comparable0 comparable historical reports |
| 7 cis-alpha-Bergamotene 43.525 | 0.02%Context not comparable0 comparable historical reports |
| 70 Unidentified 59.534 | 0.23%Context not comparable0 comparable historical reports |
| 71 epi-alpha-Bisabolol 59.689 | 0.18%Context not comparable0 comparable historical reports |
| 72 cis-alpha-trans-Bergamotol 59.890 | 7.93%Context not comparable0 comparable historical reports |
| 73 Unidentified 60.100 | 0.25%Context not comparable0 comparable historical reports |
| 74 Unidentified 60.286 | 0.89%Context not comparable0 comparable historical reports |
| 75 Unidentified 60.380 | 0.18%Context not comparable0 comparable historical reports |
| 76 Unidentified 60.500 | 0.18%Context not comparable0 comparable historical reports |
| 77 cis-epi-beta-Santalol 60.635 | 2.87%Context not comparable0 comparable historical reports |
| 78 trans-alpha-trans-Bergamotol 60.938 | 0.42%Context not comparable0 comparable historical reports |
| 79 cis-beta-Santalol 61.414 | 18.03%Context not comparable0 comparable historical reports |
| 8 alpha-Cedrene 43.703 | 0.03%Context not comparable0 comparable historical reports |
| 80 trans-epi-beta-Santalol 61.519 | 0.04%Context not comparable0 comparable historical reports |
| 81 cis-Nuciferol 61.760 | 3.43%Context not comparable0 comparable historical reports |
| 82 Santalol analogue 61.923 | 0.25%Context not comparable0 comparable historical reports |
| 83 Unidentified 62.167 | 0.49%Context not comparable0 comparable historical reports |
| 84 Unidentified 62.327 | 0.44%Context not comparable0 comparable historical reports |
| 85 trans-beta-Santalol 62.556 | 1.24%Context not comparable0 comparable historical reports |
| 86 Unidentified 62.780 | 0.93%Context not comparable0 comparable historical reports |
| 87 Unidentified 62.870 | 0.53%Context not comparable0 comparable historical reports |
| 88 cis-alpha-trans-Bergamotol analogue 63.044 | 0.30%Context not comparable0 comparable historical reports |
| 89 trans-alpha-trans-Bergamotol analogue 63.165 | 0.57%Context not comparable0 comparable historical reports |
| 9 alpha-Santalene 43.884 | 0.80%Context not comparable0 comparable historical reports |
| 90 trans-Nuciferol 63.395 | 1.58%Context not comparable0 comparable historical reports |
| 91 Unidentified 63.518 | 0.26%Context not comparable0 comparable historical reports |
| 92 cis-Lanceol 63.786 | 7.55%Context not comparable0 comparable historical reports |
| 93 Bergamatol analogue 64.020 | 0.36%Context not comparable0 comparable historical reports |
| 94 Unidentified 64.360 | 0.08%Context not comparable0 comparable historical reports |
| 95 Unidentified 64.490 | 0.08%Context not comparable0 comparable historical reports |
| 96 Unidentified 64.670 | 0.04%Context not comparable0 comparable historical reports |
| 97 Unidentified 64.776 | 0.07%Context not comparable0 comparable historical reports |
| 98 Unidentified 64.883 | 0.10%Context not comparable0 comparable historical reports |
| 99 trans-Lanceol 65.360 | 0.57%Context not comparable0 comparable historical reports |
Observations to investigate
Open a product for the complete source context and report history.
Product listing and linked report record different identity details
botanical name: product lists “Aquilaria crassna and Santalum album”; report lists “Aquilaria crassna+Santalum”. extraction method: product lists “Steam Distilled”; report lists “Steam Distillation [Distilled”. origin: product lists “Cambodia/India”; report lists “Cambodia”. Wording or historical batch differences may explain this. Confirm identity and the stock batch with the supplier.
Agarwood (Oud) Attar across suppliers
Supplier prices and specifications, with a source for every listing.
| Oil & botanical identity | Supplier | Origin & extraction | Sizes & listed prices | GC/MS evidence | Product details |
|---|---|---|---|---|---|
| Agarwood (Oud) AttarAquilaria crassna and Santalum albumSingle oilCompare this oil | Lotus Garden BotanicalsChecked Sep 7, 4:45 AM UTC | USD 30.00–USD 11,338.00 Availability unconfirmed10 sizes / options | Review these findings1 report connected; 1 directly linked by the supplier. Read the evidence before comparing chemistry. | Buy ↗ |